避孕器材市场－全球产业规模、份额、趋势、机会和预测，依产品类型、配销通路、最终用户、地区和竞争格局划分，2021-2031年预测

全球避孕器材市场规模将从2025年的115.4亿美元成长到2031年的165.3亿美元，复合年增长率为6.17%。避孕器材涵盖一系列医疗植入物、物理屏障和子宫内避孕系统，旨在透过干扰生殖过程来预防怀孕。

主要市场驱动因素

性传染感染（STI）的日益普及是全球避孕器材市场的重要推动因素，促使人们采用屏障避孕法，同时预防意外怀孕和疾病传播。感染率的激增迫使公共卫生机构大力推广使用保险套和其他物理屏障避孕方法，从而维持了与荷尔蒙植入剂或子宫内避孕系统不同的高销售量。

主要市场挑战

长效可逆避孕方法（LARCs）的高昂成本以及发展中地区医疗基础设施的匮乏，严重限制了全球避孕器材市场的发展。与短期避孕方法不同，植入式避孕器和子宫内避孕系统需要大量的预付费用，并且需要训练有素的医务人员进行植入，因此严重依赖外部资金和完善的临床网路。

主要市场趋势

可逆男性避孕技术的出现，从根本上改变了整个产业格局，为以女性为中心的避孕方法提供了切实可行的替代方案。这一趋势的核心在于开发非激素类、血管阻塞性水凝胶，这种水凝胶能够提供与输精管结扎术相当的长期避孕效果，同时确保可逆性，从而满足男性和女性共同承担生育责任这一尚未得到充分满足的巨大需求。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球避孕器械市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型（保险套、隔膜、子宫颈帽、海绵、阴道环、子宫内避孕器（IUD）及其他）
  • 按配销通路（医院药房、零售药房、网路药房及其他）
  • 按最终用户（男性和女性）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美避孕器械市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲避孕器材市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区避孕器材市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲避孕器材市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲避孕器械市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球避孕器材市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Cooper Surgical, Inc.
• Pfizer, Inc
• Merck & Co Inc
• AbbVie, Inc
• Teva Pharmaceutical Industries Limited
• Ansell Ltd
• Bayer AG
• Mayer Laboratories Inc
• Church & Dwight Co Inc
• Reckitt Benckiser Group plc

第十六章：策略建议

第17章调查会社について・免责事项

The Global Contraceptive Devices Market will grow from USD 11.54 Billion in 2025 to USD 16.53 Billion by 2031 at a 6.17% CAGR. Contraceptive devices encompass a spectrum of medical implants, physical barriers, and intrauterine systems designed to prevent pregnancy by interfering with the reproductive process.

Key Market Drivers

The rising prevalence of sexually transmitted infections (STIs) acts as a critical catalyst for the Global Contraceptive Devices Market, necessitating the adoption of barrier methods that offer dual protection against both unintended conception and disease transmission. This surge in infection rates compels public health bodies to aggressively promote condom usage and other physical barriers, thereby sustaining high-volume sales distinct from hormonal implants or intrauterine systems. The urgency of this driver is underscored by recent epidemiological data indicating a failure to curb specific transmission rates globally.

Key Market Challenges

The high costs associated with long-acting reversible contraceptives (LARCs) and the limited healthcare infrastructure in developing regions constitute a severe restraint on the global contraceptive devices market. Unlike short-term methods, implants and intrauterine systems require significant upfront expenditure and trained medical personnel for insertion, creating a heavy dependency on external funding and robust clinical networks. When supply chains fracture or donor allocations stagnate, these higher-value devices become inaccessible to the populations that need them most. This financial and logistical disconnect prevents the conversion of potential demand into actual market adoption, effectively capping market volume and revenue potential in high-demand regions.

Key Market Trends

The emergence of reversible male contraceptive technologies is fundamentally altering the sector by introducing viable alternatives to female-centric methods. This trend centers on the development of non-hormonal, vas-occlusive hydrogels that provide long-term efficacy comparable to vasectomies while ensuring reversibility, thereby addressing the significant unmet demand for shared reproductive responsibility. These innovations are progressing rapidly through clinical validation, proving that reliable male-focused devices can effectively disrupt the traditional market reliance on condoms and permanent sterilization.

Key Market Players

• Cooper Surgical, Inc.
• Pfizer, Inc
• Merck & Co Inc
• AbbVie, Inc
• Teva Pharmaceutical Industries Limited
• Ansell Ltd
• Bayer AG
• Mayer Laboratories Inc
• Church & Dwight Co Inc
• Reckitt Benckiser Group plc

Report Scope:

In this report, the Global Contraceptive Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contraceptive Devices Market, By Product Type:

• Condoms
• Diaphragms
• Cervical Caps
• Sponges
• Vaginal Rings
• Intra Uterine Devices (IUDs)
• and Others

Contraceptive Devices Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• and Others

Contraceptive Devices Market, By End User:

• Male
• and Female

Contraceptive Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contraceptive Devices Market.

Available Customizations:

Global Contraceptive Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contraceptive Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUDs), and Others)
  • 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
  • 5.2.3. By End User (Male, and Female)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Contraceptive Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Distribution Channel
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Contraceptive Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Distribution Channel
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Contraceptive Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Distribution Channel
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Contraceptive Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Distribution Channel
      • 6.3.3.2.3. By End User

7. Europe Contraceptive Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Distribution Channel
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Contraceptive Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Distribution Channel
      • 7.3.1.2.3. By End User
  • 7.3.2. France Contraceptive Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Distribution Channel
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Contraceptive Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Distribution Channel
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Contraceptive Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Distribution Channel
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Contraceptive Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Distribution Channel
      • 7.3.5.2.3. By End User

8. Asia Pacific Contraceptive Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Distribution Channel
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Contraceptive Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Distribution Channel
      • 8.3.1.2.3. By End User
  • 8.3.2. India Contraceptive Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Distribution Channel
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Contraceptive Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Distribution Channel
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Contraceptive Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Distribution Channel
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Contraceptive Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Distribution Channel
      • 8.3.5.2.3. By End User

9. Middle East & Africa Contraceptive Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Distribution Channel
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Contraceptive Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Distribution Channel
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Contraceptive Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Distribution Channel
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Contraceptive Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Distribution Channel
      • 9.3.3.2.3. By End User

10. South America Contraceptive Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Distribution Channel
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Contraceptive Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Distribution Channel
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Contraceptive Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Distribution Channel
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Contraceptive Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Distribution Channel
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Contraceptive Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cooper Surgical, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Pfizer, Inc
• 15.3. Merck & Co Inc
• 15.4. AbbVie, Inc
• 15.5. Teva Pharmaceutical Industries Limited
• 15.6. Ansell Ltd
• 15.7. Bayer AG
• 15.8. Mayer Laboratories Inc
• 15.9. Church & Dwight Co Inc
• 15.10. Reckitt Benckiser Group plc

16. Strategic Recommendations

17. About Us & Disclaimer